Existing research has revealed that the abnormal expression of Lp‐PLA2 and CTRP3 in the serum of patients with coronary heart disease (CHD) exists,34, 35, 36, 37 but the regularity and diagnostic value of Lp‐PLA2 and CTRP3 in the progression of CVD should be determined in depth. The gene discussed is C1QTNF3; the disease is coronary artery disorder.